BIPROGY (8056) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
20 Oct, 2026Executive summary
Q1 FY March 2026 revenue rose 9.6% YoY to ¥96,844 million, while operating profit grew 30.3% to ¥8,569 million.
Adjusted operating profit increased 23.9% to ¥7,841 million; profit attributable to owners of parent rose 19.1% to ¥5,827 million.
Orders rose 7.6% to ¥95.3B; backlog scheduled for revenue in FY March 2026 increased 6.1% to ¥137.6B.
Financial highlights
Gross profit increased 9.9% YoY to ¥23,788 million; SG&A rose 4.2% to ¥15.9B, driven by personnel and business-expansion costs and remaining within plan.
Revenue growth included ¥4.1B from services and ¥4.4B from product sales.
Basic EPS increased to ¥59.42 from ¥48.66 YoY.
Cash and cash equivalents were ¥68,743 million at quarter-end, up ¥3,942 million from the prior year-end; operating cash flow was ¥21,702 million.
Outlook and guidance
FY March 2026 forecasts unchanged: revenue ¥420.0B, operating profit ¥42.6B, adjusted operating profit ¥42.0B and parent-attributable profit ¥29.0B.
Full-year forecasts imply operating and adjusted operating margins of 10.1% and 10.0%; Q1 progress was described as on track.
Full-year basic EPS is forecast at ¥298.66.
Latest events from BIPROGY
- Q1 operating profit rose 22% as revenue, orders, and backlog grew.8056
Q1 2024 - H1 revenue rose 11.8% and operating profit 21.9%; FY guidance stayed unchanged.8056
Q2 2024 - Strong DX demand lifted FYMar2024 results; growth investment supports FYMar2025 expansion.8056
Q4 2024 - 9M revenue and operating profit grew; full-year forecasts and dividends rose.8056
Q3 2024 - Deferred product sales cut Q1 profit, while orders surged and FY2027 guidance stayed unchanged.8056
Q1 2027 - Q1 revenue and operating profit grew, with full-year guidance unchanged.8056
Q1 2025 - Revenue and operating profit rose, but net profit declined; full-year guidance was unchanged.8056
Q2 2025 - Revenue and orders grew, lifting the FY revenue forecast despite lower net profit.8056
Q3 2025 - Revenue and operating profit grew; FY2027 revenue target rose to ¥440bn.8056
Q4 2025